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Chronic infection with Plasmodium falciparum was
epidemiologically associated with endemic Burkitt’s
lymphoma, a mature B cell cancer characterized
by chromosome translocation between the c-myc
oncogene and Igh, over 50 years ago. Whether infec-
tion promotes B cell lymphoma, and if so by which
mechanism, remains unknown. To investigate the
relationship between parasitic disease and lympho-
magenesis, we used Plasmodium chabaudi (Pc) to
produce chronic malaria infection in mice. Pc in-
duces prolonged expansion of germinal centers
(GCs), unique compartments in which B cells
undergo rapid clonal expansion and express activa-
tion-induced cytidine deaminase (AID), a DNA muta-
tor. GC B cells elicited during Pc infection suffer
widespread DNA damage, leading to chromosome
translocations. Although infection does not change
the overall rate, it modifies lymphomagenesis to
favor mature B cell lymphomas that are AID depen-
dent and show chromosome translocations. Thus,
malaria infection favorsmature B cell cancers by elic-
iting protracted AID expression in GC B cells.
INTRODUCTION
Many pathogens have been implicated as etiologic agents in the
development of human cancer. For example, individuals infected
with Epstein-Barr virus (EBV), hepatitis C virus, HIV,Helicobacter
pylori, or Plasmodium falciparum are all at higher than average
risk of developing B cell lymphoma (de Martel et al., 2012; Epel-
degui et al., 2010; Kutok and Wang, 2006; Marcucci and Mele,
2011; Molyneux et al., 2012; Zucca et al., 2000; Zur Hausen,
2009). Although viruses can promote neoplasia directly, by deliv-
ering virally encoded cancer genes to target cells, the link
between most pathogens and tumor development remains
obscure (Karin et al., 2006; Mesri et al., 2014). For instance,
endemic Burkitt’s lymphoma (eBL), a lymphoma of GC origin,
is among the most common childhood cancers in Africa, and itoccurs at higher incidence in areas in which Plasmodium falcip-
arum infection is endemic. This epidemiologic association is
poorly understood in part because eBL cells are infected with
EBV, which can induce B cell malignancy, and there is little
insight into how malaria might play an additional role (Burkitt,
1961; Kutok and Wang, 2006; Magrath, 2012; Molyneux et al.,
2012).
Based on histologic, molecular, and gene expression analysis,
it has been proposed that BL cells represent transformed GC
B cells that carry t(8;14) chromosome translocations (Klein and
Dalla-Favera, 2008; Ku¨ppers et al., 1999; Magrath, 1990; Shaffer
et al., 2002; Victora et al., 2012). This translocation joins c-myc to
immunoglobulin (Ig) gene loci and thereby deregulates c-myc
expression. However, deregulated c-myc alone is not sufficient
to produce lymphoma (Adams et al., 1985; Janz et al., 2003;
Leder et al., 1986), and transformation requires additional lesions
in genes encoding proteins, such as P53, which regulates cell-
cycle checkpoints and apoptosis (Gaidano et al., 1991; Love
et al., 2012). Neither p53mutation nor EBV infection are eBL spe-
cific, as they occur broadly in lymphoid malignancies (Cesar-
man, 2014; Forbes et al., 2015; Koduru et al., 1997; Kutok and
Wang, 2006; Saha and Robertson, 2011). In contrast, malaria
is exquisitely associated with eBL (Magrath, 2012; Molyneux
et al., 2012).
GC B cells are rapidly dividing cells that are unique in ex-
pressing high levels of activation-induced cytidine deaminase
(AID), a mutator enzyme that deaminates cytidines and pro-
duces U:G mismatches in Ig gene loci to initiate somatic
hypermutation (SHM) and class-switch recombination (CSR) of
antibodies (Muramatsu et al., 2000; Petersen-Mahrt et al.,
2002; Revy et al., 2000). Although AID has a strong preference
for Ig gene loci, it is not entirely Ig specific, and it produces
off-target mutations or DNA breaks in oncogenes, including
c-myc, that lead to translocations in activated B cells in vitro
and in IL-6 transgenic mice that develop polyclonal plasmacyto-
sis (Klein et al., 2011; Pasqualucci et al., 2001; Ramiro et al.,
2004; Robbiani et al., 2008).
Here, we show that in the absence of p53, Pc infection results
in development of mature B cell lymphoma. Malaria infection
alters lymphomagenesis to favor development of mature GC or
post-GC origin B cell lymphomas and also destabilizes the
genome in rapidly dividing AID-expressing GC B cells.Cell 162, 727–737, August 13, 2015 ª2015 Elsevier Inc. 727
Figure 1. B Cell Responses to Plasmodium
Infection
(A and B) The total spleen cellularity, the total
B cells (A), and the germinal center B cells (B),
following Pc infection. Themeanwith SD is shown;
at least five mice were evaluated for each time
point.
(C) AID expression is confined to germinal center
B cells. Representative flow cytometry plots of
splenocytes from Plasmodium-infected AIDGFP
mice. The top row shows the relative expansion of
germinal center (green) over non-germinal center
(red gate) B cells over time (gated on B220+). The
bottom row shows the expression of AIDGFP in
non-B cells (B220, gray), non-germinal center B
cells (B220+CD38+CD95, red), and germinal
center B cells (B220+CD38CD95+, green). At
least three mice were evaluated for each time
point.
(D) AID protein in malaria GC B cells. Gating
strategy (left) and semiquantitative western blot
analysis (right) identifying AID in both light zone
(LZ) and dark zone (DZ) cells sorted 3 weeks post-
inoculation. The triangles indicate 3-fold serial
dilution. AID/ and wild-type (WT) control lanes
are from in vitro-activated B cells of the respective
genotypes. One of two independent experiments
is shown.
See also Figure S1.RESULTS
Plasmodium Infection Induces AID-Expressing
Germinal Centers
We used Plasmodium chabaudi (Pc) to establish chronic malaria
infection in mice. In agreement with previous reports (Achtman
et al., 2007; Horne-Debets et al., 2013), parasitemia peaked
between 7 and 10 days after infection and was followed by an
increase in total spleen cellularity (mean of 286.6 mio cells/
spleen, 4-fold expansion at 3 weeks), including B lymphocytes728 Cell 162, 727–737, August 13, 2015 ª2015 Elsevier Inc.(mean of 130.4 mio B cells/spleen,
3-fold expansion at 4 weeks; Figures 1A
and S1A). Strikingly, splenic GC B cells
expanded by 63-fold (mean of 15.4 mio
GC B cells/spleen at 3 weeks), and
this response was sustained for over
10 weeks (Figure 1B). We conclude
that Plasmodium infection induces a
robust and long-lasting expansion of GC
B cells.
Ig somatic mutation and class-switch
recombination are initiated by AID, a cyti-
dine deaminase (Muramatsu et al., 2000;
Petersen-Mahrt et al., 2002; Revy et al.,
2000). This enzyme is typically restricted
to activated B cells in germinal centers
(GCs), but malaria infection produces
widespread B cell activation (Scholzen
and Sauerwein, 2013). To determine if
AID is restricted to GCs during Pc infec-tion, we examined AIDGFP reporter mice (Crouch et al., 2007).
We found that AID expression was restricted to GC B cells and
was sustained over a period of at least 10 weeks (Figures 1C
and S1B). To confirm AID protein expression, we sorted GC
B cells into dark- and light-zone cells and performed western
blot analysis. As expected, AID was found mainly in dark-zone
cells, which contained three times more AID than did light-
zone cells or in vitro-activated B cells (Figure 1D). We conclude
that AID is primarily expressed in Plasmodium-induced GC
B cells.
Widespread Chromosome Translocations in Malaria
Germinal Centers
AID and replication-associated stress can independently pro-
duce DNA breaks and translocations in cultured B cells (Barlow
et al., 2013; Hakim et al., 2012; Klein et al., 2011). To map the
DNA damage caused by Plasmodium infection in vivo, we
adapted a previously described next-generation translocation
capture and sequencing method (TC-seq; Klein et al., 2011).
Mice with an I-SceI recognition site at c-myc (MycI) were bred
to a ROSAerISCEI transgene (encoding for I-SceI fused to the
estrogen receptor ligand binding domain, er) and to either
AID-deficient or AID-overexpressing mice (ROSAAIDer; see
the Experimental Procedures; Figure S2). Compound MycI/I
ROSAerISCEI/erISCEIAID/ and MycI/IROSAerISCEI/AIDer mice were
infected with Plasmodium and treated with Tamoxifen at the
peak of the GC response, to induce the nuclear shuttling of
erISCEI in the absence or presence of AID, and translocations
between the DNA break at MycI on chromosome 15 and lesions
in the rest of the genome were captured by TC-seq (Figure 2A).
We recovered 191,150 and 65,905 unique rearrangements to
the I-SceI site in MycI from 105 million AID-deficient or AID-pro-
ficient malaria GC B cells, respectively (see the Experimental
Procedures). In agreement with previous in vitro experiments
(Klein et al., 2011), malaria rearrangements were preferentially
intrachromosomal (95.2% versus 94.3% of all rearrangement-
associated reads, in the absence or presence of AID, respec-
tively; Figure 2B) and enriched at the I-SceI site (Figure 2C).
Regardless of AID expression, rearrangements were significantly
increased in genic regions over the predicted random distribu-
tion of 40.1% (Figure 2D) and favored more actively transcribed
genes (Figure 2E). Consistent with this, the asymmetric dis-
tribution of events in the direction of transcription at the I-SceI
site was less pronounced in malaria GCs than in vitro-stimulated
B cells, which express higher levels of c-myc (Figures 2C
and S2E; Klein et al., 2011; Shaffer et al., 2001; Thomas
and Rothstein, 1989). We conclude that the overall distribu-
tion of chromosome rearrangements induced by Plasmodium
in vivo is similar to the one observed in retrovirally infected cells
in vitro.
AID-Independent Damage Involves Sites of DNA
Replication-Associated Fragility
Early replication fragile sites (ERFSs) are a set of genomic re-
gions prone to breakage during DNA replication (Barlow et al.,
2013). To assess the contribution of DNA replication to
malaria-induced rearrangements, we analyzed their occurrence
within hotspots of viral integration at ERFSs (M.J. and I.T.S., un-
published data; Barlow et al., 2013). The fraction of transloca-
tions in ERFSs was similar in the presence and absence of AID
(1.5% and 2% of total, respectively) and significantly enriched
over the random distribution as determined by Monte-Carlo
simulation (Figure 3A). ERFS translocations preferred genic re-
gions andmore highly transcribed genes (Figure S3). In contrast,
no enrichment was observedwithin common fragile sites (CFSs),
which are late-replicating regions that preferentially break during
mitosis (Figure 3B; Helmrich et al., 2006). We conclude that in
malaria GC B cells DNA damage preferentially occurs at ERFSs,
regardless of AID.AID Damages the Genome of Malaria GC B Cells
To determine whether AID destabilizes specific regions in the
GC B cell genome, we compared AID-deficient and AID-
proficient TC-seq libraries for local accumulations of transloca-
tions using stringent criteria (Wang et al., 2014). As expected,
hotspots of AID-dependent translocation were observed at
the Igh locus, with accumulations involving the switch regions
Sm, Sg2b, and Sg2a (Figure 4A; Table S1). In contrast, AID
translocations from B cells activated in vitro formed hotspots
in all switch regions, and particularly at Sm, Sg1, and Sg3 (Fig-
ure 4A). An additional 15 hotspots were identified in non-Ig re-
gions, and off-target AID-dependent mutational activity was
confirmed at c-myc and near Ly6e (Figures 4B, 4C, and S4A;
Table S1). In agreement with previous reports, AID transloca-
tions were enriched in genic regions and favored more highly
transcribed genes (Figures S4B and S4C; Klein et al., 2011;
Wang et al., 2014). Moreover, none of the AID translocation
off targets identified in vivo were shared with those from the
in vitro dataset (Table S1; Klein et al., 2011). Altogether, trans-
locations within AID-dependent hotspots, including the Igh
locus, comprised only 0.7% of total. We conclude that AID
is not limited to, but primarily destabilizes, Ig regions in GC
B cells.
AID Promotes Late-Stage Lymphomas
In addition to deregulated c-myc, BLs bear frequent mutation of
p53 (Gaidano et al., 1991; Love et al., 2012). To model this phe-
nomenon, we produced mice that carry a B cell-specific defi-
ciency in p53 (CD19cre/+p53lox/lox) and are either proficient or
deficient for AID. B lymphocyte development was not signifi-
cantly altered in these mice despite efficient p53 deletion (Fig-
ure S5). To mimic the chronic exposure in areas of endemic
malaria, the two cohorts were repeatedly infected with Pc and
monitored for disease. Mice developed lymphomas in an AID-
dependent manner (Figure 5). Malaria infection was not required
for lymphoma development but altered the phenotype to favor
more mature B cell lymphomas (Figure 6).
Whereas none of 11 wild-type mice became ill after infection,
the two p53-deficient groups succumbed with a median of
60 weeks for CD19cre/+p53lox/lox and 58 weeks for CD19cre/+
p53lox/loxAID/ (p = 0.8 with the Mantel-Cox test; Figure 5A).
However, all of 12CD19cre/+p53lox/lox mice developed lymphoma
while only 5 out of 15 CD19cre/+p53lox/loxAID/ mice had evi-
dence of lymphoma (33%, p < 0.0004 with Fisher’s exact test;
Figures 5B and 5C). Themajority of theCD19cre/+p53lox/loxAID/
mice (67%) presented with splenomegaly associated with
marked extramedullary hematopoiesis but no histologic evi-
dence of cancer (Figures 5B–5D). Consistent with lack of
transformation, splenocytes from these mice were unable to
expand in vitro (n = 5), as opposed to 3 out of 4 control
lymphomas (observation period of 3 weeks). Moreover, lym-
phoma developed only in 1 out of 4 immunodeficient mice, in
which CD19
cre/+
p53lox/loxAID/ splenocytes from malaria-in-
fected mice had been transplanted (Figure S5D). Finally, all of
the CD19cre/+p53lox/loxAID/ mice analyzed showed persistent
parasitemia (n = 5), low red blood cell counts, decreased hemo-
globin levels, and increased mean cell volume in peripheral
blood (Figure S5E). All together, these findings are consistentCell 162, 727–737, August 13, 2015 ª2015 Elsevier Inc. 729
Figure 2. Translocations in Malaria GC B Cells
(A) A schematic diagram of the protocol to identify genomic rearrangements induced by Plasmodium in vivo.
(B) The chromosome distribution of rearrangement-associated reads captured by I-SceI breaks on chromosome 15.
(C) The profile of rearrangements around the I-SceI site. The dotted lines represent AID-deficient samples.
(D) The proportion of genic rearrangements.
(E) The frequency of rearrangements at genes with various levels of transcription. The empty bars represent AID-deficient samples. The dashed line represents
the expected frequency based on random model.
For all, rearrangements from malaria GC B cells are compared to cultured B cells (Klein et al., 2011). See also Figure S2.with the majority of CD19cre/+p53lox/loxAID/ mice succumbing
to a condition characterized by reactive extramedullary hemato-
poiesis in response to ongoing malaria infection. In contrast, all
AID-sufficient mice developed lymphoma.
To determine whether AID is required to control malaria, we
inoculated AID/ mice and monitored parasitemia over time.
Regardless of p53, AID deficiency did not alter the acute infec-730 Cell 162, 727–737, August 13, 2015 ª2015 Elsevier Inc.tion, but AID was required to quench parasitemia in the chronic
phase (Figures S5F). In agreement with this finding, AID defi-
ciency was associated with anemia, splenomegaly, extramedul-
lary hematopoiesis, and reduced survival (Figures S5G–S5I; data
not shown). We conclude that AID promotes Plasmodium-
induced lymphomagenesis, but it is required to control chronic
malaria infection.
Figure 3. AID-Independent DNA Damage in Regions of DNA Repli-
cation-Associated Fragility
(A) The observed number of chromosome rearrangements within hotspots of
viral integration at early replication fragile sites (ERFSs, red dot), as compared
to a random Monte-Carlo simulation (p < 0.001 for both).
(B) The number of chromosome rearrangements within common fragile sites
(CFSs, red dot), as compared to a random Monte-Carlo simulation.
See also Figure S3.
Figure 4. AID Contributes to Plasmodium-Induced DNA Damage
(A) Translocations at the physiologic AID target Igh. The red rectangles indicate
the location of AID hotspots, and 4-kb regions at these hotspots are magnified
on top, where vertical lines each represent a unique translocation event. The
numbers on top indicate the total of translocations at each hotspot region. The
rearrangements obtained in cultured B cells retrovirally expressing AID are
shown for comparison (Klein et al., 2011). TPKT is the normalized number of
translocations per kilobase per 1,000 translocations in the library.
(B) Examples of non-Igh hotspots of AID-dependent translocation induced
by malaria. A 1-kb region is shown, with each vertical line representing a
unique translocation. The numbers on the left indicate the total number of
translocations.
(C) A mutational analysis of malaria GC B cells DNA by MutPE-seq. For c-myc,
two adjacent regions in intron 1 were analyzed. *p < 0.000001 for all (one-tailed
Student’s t test).
See also Figure S4 and Table S1.Phenotype and Karyotype of Plasmodium-Induced
Lymphoma
We used flow cytometry to characterize the phenotype of lym-
phomas arising in AID-sufficient CD19cre/+p53lox/lox mice.
Infected and uninfected mice developed lymphoma with similar
kinetics (median of 60 weeks for infected and 63 weeks for unin-
fected; p = 0.07 with the Mantel-Cox test; Figure S6A). However,
malaria-infectedmice developed B cell lymphomas, a significant
majority of which showed a more mature phenotype consistent
with GC origin (72.7%; n = 11; Ig-switched or CD138+),
while most uninfected controls developed pre-GC lymphomas
(83.3%; n = 12; p < 0.01 with Fisher’s exact test; Figures 6A
and S6B; Tables 1, S2, and S3). As a control, we repeatedly
immunized a cohort of AID-sufficient CD19cre/+p53lox/lox mice
with sheep red blood cells (SRBCs), a well-characterized antigen
that induces long-lived germinal centers. Survival was similar in
SRBC-immunized mice (median of 68 weeks; p > 0.2 with the
Mantel-Cox test; Figure S6A). However, in contrast to malaria,
only a minority of SRBC-associated lymphomas displayed a
post-GC phenotype (p < 0.03, with Fisher’s exact test; Fig-
ure S5C; Table S4). We conclude that Plasmodium infection,
unlike SRBC immunization, causes a shift toward amoremature,
post-GC lymphoma phenotype.
Malaria-associated Burkitt’s lymphoma bears characteristic
chromosome translocation of c-myc to Ig genes (Adams et al.,
1983; Dalla-Favera et al., 1982; Hamlyn and Rabbitts, 1983;
Taub et al., 1982). To determine whether Plasmodium-induced
lymphoma in this model was associated with translocations,
we performed multicolor-FISH (M-FISH) analysis of tumor meta-
phase spreads. We found that all of the informative lymphomas(n = 7) contained clonal translocations, four tumors displayed
multiple translocations (L4, L23, L24, and L62) and one (L62)
had a complex translocation involving three chromosomes (Fig-
ure 6B; Table 1). Lymphoma L23 had a T(12;15) between
chromosomes 12 and 15, similar to the c-myc/Igh translocation
found in pristane-induced plasmacytoma (Figure 6B; Potter and
Wiener, 1992). To examine the L23 lymphoma at higher
resolution, we sequenced its genome (see the ExperimentalCell 162, 727–737, August 13, 2015 ª2015 Elsevier Inc. 731
Figure 5. P53 Suppresses and AID Promotes Plasmodium-Induced Lymphoma
(A) Survival of Plasmodium-infected mice. All mice are also CD19cre/+.
(B) Spleen histology of Plasmodium-infected CD19cre/+p53lox/lox mice. L4 is AID-proficient lymphoma and S2 is AID-deficient benign B cell hyperplasia with
marked extramedullary hematopoiesis.
(C) Lymphoma versus benign hyperplasia in Plasmodium-infected mice. Lymphoid tissues were evaluated by histology, immunohistochemistry, and flow
cytometry. ‘‘Benign hyperplasia’’ indicates mice with splenomegaly, but with normal B cell distribution and B220+ cells confined to follicular areas. ‘‘Atypical
hyperplasia or early neoplasia’’ denotes splenomegaly and B220+ cells expanding into the periarteriolar lymphoid sheats (PALS). ‘‘Lymphoma’’ defines abnormal
lymphoid tissue architecture and/or dissemination to multiple organs.
(D) Extramedullary hematopoiesis in Plasmodium-infected mice. Spleen sections were evaluated for the degree of extramedullary hematopoiesis.
See also Figure S5 and Table S2.Procedures; Figure S7). Bioinformatic analysis confirmed the
presence of a c-myc/Igh translocation at T(12;15), as well as
the expected deletions at the p53 locus and at the physiologi-
cally rearranged Igh and Igk loci (Figure 6C; data not shown).
Sequence analysis also identified the breakpoint of T(18;3) and
revealed additional intra- and interchromosomal rearrange-
ments, which were not detected by M-FISH (Figures 6C, S7B,
and S7C; Table S5). Notably, 5 out of 8 interchromosomal break-
points involved known AID targets (Figure 6C). We conclude that
L23 carries numerous chromosome rearrangements, including
the c-myc/Igh translocation characteristic of human Burkitt’s
lymphoma, and that AID shapes this lymphoma’s genome.
DISCUSSION
Burkitt’s lymphoma, a mature B cell lymphoma, occurs sporad-
ically, but at higher incidence among immunodeficient individ-
uals and in equatorial areas endemic for malaria (Cesarman,
2014; Magrath, 2012; Molyneux et al., 2012). In addition to ma-
laria infection, most individuals developing eBL are also infected
by EBV, a virus that encodes oncogenic proteins that can pro-
mote lymphomagenesis (Cesarman, 2014; Kutok and Wang,
2006; Magrath, 2012; Mesri et al., 2014; Molyneux et al., 2012;
Zhang et al., 2012). Thus, EBV is thought to play a direct role in732 Cell 162, 727–737, August 13, 2015 ª2015 Elsevier Inc.the transformation process. In contrast, malaria’s contribution
to lymphoma has remained elusive. We found that Plasmodium
does not alter the incidence of cancers arising in B cells that
carry a homozygous deletion of p53. Thus, Plasmodium infection
alone does not induce cancer, and hence the requirement for
EBV and additional transforming events. Instead, the parasitic
infection alters lymphoma phenotype to favor more mature
B cell lymphoma by inducing chronic GCs containing AID-ex-
pressing B cells.
Mature B cell lymphomas, including eBL, are frequently asso-
ciated with hallmark oncogenic translocations and display
phenotypic and molecular characteristics of GC B cells. How-
ever, it is not clear whether translocations are acquired within
germinal centers or at earlier developmental stages (Shaffer
et al., 2002). Supporting the notion that GCs are a lymphoma-
genic environment, we document widespread chromosome re-
arrangements occurring within malaria GCs. This is consistent
with the high levels of AID and DNA replication in these rapidly
proliferating cells (Gitlin et al., 2014; Robbiani and Nussenzweig,
2013; Victora and Nussenzweig, 2012). Early replication fragile
sites (ERFSs) map to sites of early DNA replication and are
particularly vulnerable to fork collapse. ERFS DNA is GC-rich
and mostly euchromatic (Barlow et al., 2013). Translocations
were significantly enriched at ERFSs, but not at common fragile
Figure 6. Genomic Rearrangements in Plasmodium-Induced
Lymphomas
(A) Distribution of lymphoma phenotypes in Plasmodium-infected and control
uninfected CD19cre/+p53lox/lox mice.
(B) Representative M-FISH images of metaphases from Plasmodium-induced
CD19cre/+p53lox/lox lymphomas. Arrows point to chromosomeswith detectable
translocations.
(C) Circos diagram of the L23 genome. Red arches represent interchromo-
somal rearrangements, and green arches intrachromosomal ones. For genic
rearrangements, the name of the gene is indicated. Asterisks indicate if the
recombined site is a known AID target (red; Hakim et al., 2012; Klein et al.,
2011) or within hotspots of viral integration at ERFSs (black; M.J. and I.T.S.,
unpublished data).
See also Figures S6 and S7 and Tables S3, S4, and S5.sites (CFSs). This finding was unanticipated given that CFSs had
been previously implicated in the genesis of lymphomagenic re-
arrangements (Chesi et al., 1998; Kameoka et al., 2004).
AID was not absolutely required for malaria-associated lym-
phomagenesis since a small number of the AID/ p53-deficient
mice also developed lymphoma. Moreover, only a fraction of
rearrangements found in malaria GC B cells in vivo could be
attributed to AID. Nevertheless, AID strongly promoted lympho-
magenesis possibly because in addition to causing transloca-
tions (Chiarle et al., 2011; Klein et al., 2011; Ramiro et al.,
2004; Robbiani et al., 2008, 2009), it can mutate cancer genes
directly (Hakim et al., 2012; Liu et al., 2008; Pasqualucci et al.,
2001).
In the absence of Plasmodium superinfection EBV is associ-
ated with B cell cancers other than eBL. For example, EBV is
commonly detected in plasmablastic and Hodgkin’s lymphoma,
and approximately one-third of immunodeficiency-associated
diffuse large B cell lymphoma is EBV positive (Cesarman,
2014). Moreover, when immune surveillance is impaired, the
EBV gene LMP1 alone directly promotes B cell transformation
(Zhang et al., 2012). Thus, EBV is oncogenic in B cells, but alone
cannot account for the specific phenotype of eBL. Similarly, mu-
tations in p53 and other cancer genes are not exclusive for eBL,
as they occur broadly in B cell malignancy (O’Shea et al., 2008;
Young et al., 2008). Instead, the distinctive phenotype of eBL is
specifically associated with malaria. Essentially all eBLs bear
c-myc translocation to Ig regions, and AID is accountable for
the DNA lesions at both sites, leading to their translocation (Rob-
biani et al., 2008). By eliciting protracted, high levels of AID in
GCs, malaria acts as a disease modifier and predisposes B cells
to acquire c-myc translocation at a stage in B cell development
thatmirrors themolecular and phenotypic characteristics of eBL.EXPERIMENTAL PROCEDURES
Mice and Parasites
All experiments were performed in agreement with protocols approved by the
Rockefeller University Institutional Animal Care and Use Committee. Mutant
mice used in this study include CD19cre/cre (Cd19tm1(cre)Cgn;Rickert et al.,
1997), p53lox/lox (Trp53tm1Brn;Marino et al., 2000), AID/ (Muramatsu et al.,
2000), AIDGFP (Crouch et al., 2007), IgHI96k/+ (Bothmer et al., 2010), MycI/I
and IgHI/I (Robbiani et al., 2008), and IgkAID (Robbiani et al., 2009). The RO-
SAAIDer and ROSAerISCEI alleles were generated in-house by gene targeting
into the ROSA26 locus of C2J embryonic stem cells, as previously described
(Srinivas et al., 2001), and the loxP-flanked transcriptional stop was removed
from the germline by crossing to EIIAcre mice (B6.FVB-TgN[EIIa-Cre]
C5379Lmgd; Lakso et al., 1996). With the exception of the immunodeficient-
NRG strain (NOD.Cg-Rag1tm1Mom Il2rgtm1Wjl/SzJ; Pearson et al., 2008), mice
used in this study were either generated in C57Bl/6 background or back-
crossed into it for at least 11 generations. Plasmodium chabaudi chabaudi
ASS (Pc; MRA-429; Carter and Walliker, 1975; Peters and Robinson, 2000)
was obtained through the MR4 as part of the BEI Resources Repository,
NIAID, NIH.
Plasmodium Infection
Parasites were maintained as frozen stocks and passaged in wild-type mice.
For the analysis of B cell responses, 6- to 12-week-old mice were injected
intraperitoneally (i.p.) with 105 Pc-infected erythrocytes from a donor mouse.
In tumor experiments, 6- to 8-week-old mice were used for primary infection
and secondary and tertiary infections were performed at 8-week intervals us-
ing the same dose and route. Parasitemia was monitored by flow cytometryCell 162, 727–737, August 13, 2015 ª2015 Elsevier Inc. 733
Table 1. Karyotype and Phenotype of Lymphomas in P. chabaudi-Infected CD19cre/+p53lox/lox Mice
Tumor ID Karyotype Phenotype S MLN sbLN oLN L
L21 nd CD3+ +    +
L4 T(11;15) T(8;17) T(12;11) T(15;19)a CD19+ IgM IgD IgK+ CD138 CD38+/ FAS GL7 + + + + 
L9 no metaphases CD19+ IgM IgD IgK+ CD138 CD38+ FAS+ GL7 + + + + 
L23 T(12;15) T(18;3) CD19 IgM IgD IgK CD138+ CD38 FAS GL7dim +    +
L24 T(3;11) T(18;1) CD19+ IgM IgD IgK+ CD138+ CD38+ FASdim GL7 + + + + 
L33 T(2;16) CD19+ IgM+ IgD IgK+ CD138+ CD38+ FAS+ GL7 + + + + 
L52 no metaphases CD19+ IgM IgD IgK+ CD138 CD38+/ FAS GL7+ +   + 
L62 T(8;13)b T(3;17;3;4) CD19+ IgM+ IgD IgK+ CD138+ CD38+ FAS+ GL7dim + + + + 
L68 nd CD19 IgM IgD IgK CD138+ CD38+ FASdim GL7  + + + 
L31 T(2;10) CD19+ IgM+ IgD+ IgK+ CD138 CD38+ FASdim GL7 + + + + +
L39 T(7;13) CD19+ IgM+ IgD IgK+ CD138 CD38+ FAS+ GL7+ +   + +
L69 nd CD19+ IgM+ IgD+ IgK+ CD138 CD38+ FAS GL7 +    
Translocations are clonal if present in all metaphases. At least 20metaphaseswere analyzed for each tumor. The extent of macroscopic tumor dissem-
ination at necropsy is as follows: S, spleen; MLN, mesenterial lymph nodes; sbLN, submandibular lymph nodes; oLN, axillary, thoracal, or inguinal
(other) lymph nodes; L, liver or other metastasis. nd, not determined. See also Figure S6 and Table S2.
aSporadic translocation.
bClonal, reciprocal translocation.after staining 1 ml of blood with anti-Ter119 (eBiosciences) and Hoechst33342
(Invitrogen) for 30 min at room temperature, and confirmed by blood smear
analysis.
Immunization with Sheep Red Blood Cells
1 ml of sheep red blood cells (SRBCs) (Colorado Serum Company) was diluted
with 4 ml PBS, and 0.2 ml of the mix was injected intraperitoneally. Mice were
immunized five times at 4-week intervals.
Flow Cytometry
Single-cell suspensions of lymphatic or tumor tissues were stained after eryth-
rocyte lysis with fluorophore-conjugated anti-mouse antibodies (from BD
PharMingen or eBiosciences) to detect CD19 (clone 1D3), B220 (RA3-6B2),
GL-7, FAS (Jo2), CD38 (90), CD86 (GL1), immunoglobulin M (IgM) (AF6.78,
II/41), immunoglobulin D (IgD) (11-26c.2a), immunoglobulin K (IgK) (187.1),
CD138 (281.2), CD43 (S7), CD3 (145-2C11), or biotin-conjugated antibody
for CXCR4 (2B11), followed by streptavidin-APC. Samples were acquired on
a FACSCalibur or Fortessa instrument (Becton Dickinson) and analyzed with
FlowJo software.
Western Blot
Germinal center light- and dark-zone (LZ and DZ) B cells were purified from
spleens of Pc-infected mice at 3 weeks post-inoculation. Upon magnetic
enrichment with anti-CD19microbeads (Miltenyi Biotech), B cells were stained
with antibodies to sort DZ (B220+CD38GL7+FAS+CXCR4hiCD86lo) and LZ
(B220+CD38GL7+FAS+CXCR4loCD86hi) B cells with a FACSVantage SE
with Diva option or FACSAria instruments (Becton Dickinson, >95% purity).
Resting B lymphocytes from wild-type and AID/ mice were isolated from
spleens by immunomagnetic depletion with anti-CD43 MicroBeads (Miltenyi
Biotech) and cultured for 4 days in the presence of LPS (25 mg/ml) and IL-4
(5 ng/ml). AID protein was detected as previously described (McBride et al.,
2008).
Purification of Malaria GC B Cells and TC-Seq Library Preparation
3–5 weeks after Plasmodium infection, MycI/IROSAerISCEI/AIDer or MycI/I
ROSAerISCEI/erISCEIAID/ mice were injected intraperitoneally with 0.8 mg
Tamoxifen in corn oil and euthanized 36 hr later. Upon ACK lysis, single-cell
suspensions of splenocytes were incubated with biotinilated antibodies to
mouse CD43 (clone S7), CD11c (N418), F4/80 (BMO), Gr-1 (RB6-8C5), and
IgD (11-26c) for 20 min on ice (all from BD PharMingen or eBiosciences).734 Cell 162, 727–737, August 13, 2015 ª2015 Elsevier Inc.Upon washing, cells were incubated with anti-biotin microbeads and nega-
tively depleted with magnetic columns (Miltenyi). This was followed by incuba-
tion with anti-CD19 microbeads and positive magnetic selection. GC B cells
purity was monitored by flow cytometry and ranged between 88%–95%.
Two TC-seq libraries for each genotype were independently generated as pre-
viously described, with capture from the I-SceI site at c-myc (Klein et al., 2011),
with the exception of using an improved linker (50-GCA GCG GAT AAC AAT
TTC ACA CAG GAC GTA CTG TGC GGC CGC T and 50-/5Phos/GCG GCC
GCA CAG TAC TTG ACT GAG CTT TA/3 ddC/). Deep sequencing was per-
formed with Illumina HiSeq, 100 cycles, paired-ends.
TC-Seq and Computational Analysis
Pooled data from two independent libraries were analyzed as previously
described (Klein et al., 2011; Wang et al., 2014), with minor modifications.
Sequencing reads were first trimmed for quality with seqtk (error rate threshold
of 0.01; Broad Institute). Reads containing primer sequences from the first
PCR reaction were discarded from subsequent analysis. Finally, reads were
mapped with SMALT (v.0.7.6; Sanger Institute), and only reads uniquely align-
ing at least 28 base pairs (bp) were included. To determine enrichment at genic
regions (Figure 2D), the following portions of the genome were excluded: 1 Mb
surrounding the I-SceI site, Igh, Igk, and Igl regions, 2-kb regions surrounding
cryptic I-SceI sites (according to the consensus [TCA][AT]GGGATA[AC]CAGG
[GCT][TC][ATC][AG][TAC]), AID-coding exons (likely representing retroviral in-
sertions), and 3 Mb at each centromere. The portion of DNA from 2 kb
upstream of the first transcription start site to the end of the last exon was
considered as genic. For the role of transcription (Figure 2E), RNA-seq data
(Hogenbirk et al., 2013) were mapped with STAR aligner (v.2.3.0.1) (Dobin
et al., 2013), using the mouse genome (mm9) and removing multiple align-
ments. Transcripts were quantified and annotated using cufflinks (v.2.2.1)
(Trapnell et al., 2013) and Ensembl annotation (release 66), and the following
regions were excluded from downstream analysis: 1 Mb surrounding the
I-SceI site, 2-kb regions surrounding cryptic I-SceI sites, and AID-coding
exons. For the analysis of enrichment within hotspots of viral integration at
ERFSs (M.J. and I.T.S., unpublished data) or CFSs (Figure 3), and of hotspots
of AID-dependent translocation (Figure 4; Table S1), rearrangements within
1 Mb surrounding the I-SceI site, within 2 kb surrounding cryptic I-SceI sites,
and within AID-coding exons were excluded from analysis. Translocation his-
tograms (Figure 4A) were normalized for the size of the library and represented
in log scale as TPKT (translocations per kilobase per 1,000 translocations in
the library): TPKT = N/(B * S * 106), where N is the number of translocations
in each bin, B is the bin size in nucleotides (in this case B = 100), and S is the
total number of translocations in the library. See also the Supplemental Exper-
imental Procedures.
M-FISH
To analyze chromosome rearrangements, metaphase spreads were obtained
from primary tumor cells upon treatment with 100 ng/ml colcemid for 1 hr and
were hybridized with the 213 mouse probe cocktail (Metasystems). Imaging
was performed on a Zeiss AxioImagerM1 equipped with amotorized scanning
stage, and Isis software was used for the analysis.
Deep-Sequencing and Computational Analysis of Lymphoma L23
Whole-genome sequencing and data analysis were performed as previously
described (Jankovic et al., 2013). In brief, 5 mg of genomic DNA was sonicated
to an average fragment size of 500 bp and processed in accordance with the
Paired-End (PE) Sample Preparation Kit protocol (Illumina). Upon quality
assessment by Bioanalyzer (Agilent), the library was subjected to paired-end
sequencing. Data were analyzed for structural variation (SV) discovery using
the following programs: Hydra-SV (Quinlan et al., 2010), BWA aligner (Li and
Durbin, 2009), Novoalign, the intersectBed software from BEDtools suite
(Quinlan and Hall, 2010), RepeatMasker, and RefSeq track from the UCSC
Genome Browser. In order to clear artifacts resulting from genetic variation,
we subtracted SVs that were similarly found in the genomes of C57BL/6 and
129/Sv mice (Jankovic et al., 2013), or of 17 other inbred strains of laboratory
mice (Keane et al., 2011). Further, SVs were removed from final analysis if any
of the two reads matched to repeats for >50%, if deletions were <1 kb, or if
their FinalWeightedSupport valuewas <2. Circular plots of genomic rearrange-
ments were generated using Circos software (Krzywinski et al., 2009).
Supplemental Experimental Procedures are available online.
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